These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18932013)
1. Pharmacist intervention reduces gastropathy risk in patients using NSAIDs. Ibañez-Cuevas V; Lopez-Briz E; Guardiola-Chorro MT; Pharm World Sci; 2008 Dec; 30(6):947-54. PubMed ID: 18932013 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users. Teichert M; Griens F; Buijs E; Wensing M; De Smet PA Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837 [TBL] [Abstract][Full Text] [Related]
3. Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies. López-Pintor E; Lumbreras B Int J Clin Pharm; 2011 Apr; 33(2):155-64. PubMed ID: 21394571 [TBL] [Abstract][Full Text] [Related]
4. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study. MacFarlane B; Matthews A; Bergin J Int J Clin Pharm; 2015 Oct; 37(5):851-6. PubMed ID: 25972205 [TBL] [Abstract][Full Text] [Related]
5. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs. Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021 [TBL] [Abstract][Full Text] [Related]
6. Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care. Lanas A; Plazas MA; Gimeno E; Muñoz-Tudurí M Gastroenterol Hepatol; 2012 Jan; 35(1):1-7. PubMed ID: 22178503 [TBL] [Abstract][Full Text] [Related]
7. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers. Lallana MJ; Feja C; Aguilar-Palacio I; Malo S; Rabanaque MJ Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149590 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study]. Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P; Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944 [TBL] [Abstract][Full Text] [Related]
9. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Koffeman AR; Valkhoff VE; Celik S; W't Jong G; Sturkenboom MC; Bindels PJ; van der Lei J; Luijsterburg PA; Bierma-Zeinstra SM Br J Gen Pract; 2014 Apr; 64(621):e191-8. PubMed ID: 24686883 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal symptoms in NSAID users in an 'average risk population': results of a large population-based study in randomly selected Dutch inhabitants. Tielemans MM; van Rossum LG; Eikendal T; Focks JJ; Laheij RJ; Jansen JB; van Oijen MG Int J Clin Pract; 2014 Apr; 68(4):512-9. PubMed ID: 24499203 [TBL] [Abstract][Full Text] [Related]
12. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. van Leen MW; van der Eijk I; Schols JM Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740 [TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice. Moore RA; Derry S; Phillips CJ; McQuay HJ BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784 [TBL] [Abstract][Full Text] [Related]
14. Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients. Pai AB J Am Pharm Assoc (2003); 2015; 55(1):e15-23; quiz e24-5. PubMed ID: 25503987 [TBL] [Abstract][Full Text] [Related]
15. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs. Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520 [TBL] [Abstract][Full Text] [Related]
16. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study. Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387 [TBL] [Abstract][Full Text] [Related]
17. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Thomas J; Straus WL; Bloom BS Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235 [TBL] [Abstract][Full Text] [Related]
18. Economic impact of pharmacists' interventions with nonsteroidal antiinflammatory drugs. Guignard AP; Couray-Targe S; Colin C; Chamba G Ann Pharmacother; 2003 Mar; 37(3):332-8. PubMed ID: 12639158 [TBL] [Abstract][Full Text] [Related]